Pharmafile Logo

Thinking creatively about patient involvement in publications

Bedrock’s freethinking spirit to reimagine publications is on course to include patients in the full end to end of the publication process.

The International Society for Medical Publication Professionals (ISMPP) 2023 European meeting theme was ‘Fueling Creativity’, and the various topics covered across the 2 days certainly got the Bedrock team thinking. How can we be creative in our approach to delivering compelling and impactful publications and medical communications? One clear area of focus at the meeting was patient involvement in publications, and our team have been reflecting on this and what it means for us as healthcare communication professionals.

Plain language summaries (PLS) have been a hot topic of ISMPP meetings for several years. The value of creating publication content tailored to non-specialist audiences (e.g. time-poor specialists/generalists, payers/policy makers, healthcare professionals [HCPs] with English as a second language, allied HCPs, lay audiences including patients and carers) is now widely recognised by publication professionals; it is becoming increasingly common to see a PLS developed alongside the publication of clinical trial data or as a standalone PLS (plain language summary of a publication). What remains less clear is how patient partners can be effectively engaged and involved throughout the entire end-to-end publication planning and development process.

Good Publication Practice (GPP) 2022 guidance recognises patients as experts who can provide important input into publications at various stages, including during publication planning, as authors and in the development of PLS (see figure below):1

- PMLiVE

ICMJE, International Committee of Medical Journal Editors; PLS, plain language summary; PLSP, plain language summary of a publication.

Patient involvement in end-to-end publication planning and development has the potential to add huge value through improving accessibility of clinical trial data to non-specialist audiences. However, it is clear that challenges remain and publication professionals need to adopt a more proactive, creative and agile approach to early engagement with patients in the process. Discussion during the ISMPP 2023 meeting brought up some interesting and thought-provoking topics and questions for us to consider moving forwards:

  • Identifying the right patient partners is a challenge – how and where can we find patients?
  • Appropriate compensation for patients’ time in supporting publication activities is permitted, though remains somewhat controversial – how should/can we navigate this?
  • There are many practical things to consider when involving patients in publications to ensure optimal contribution – how can we best make adjustments to processes and timelines to accommodate this?
  • Best-practice sharing will support the industry to progress in effective patient involvement in publications – how can we better collaborate and share key learning and information?
  • Tools and resources exist to help advocate and coordinate patient involvement in publications and to support development of PLS – how can we raise awareness and better standardise the quality of content?

Overall, great progress has been made over recent years towards involving patients in publications and much of this has focused on PLS development, which has enabled better engagement of non-specialists in healthcare. How can we, as publication and medical communications professionals, contribute to improving patient involvement in the full end-to-end publication process?

As part of our commitment to ‘reimagining publications’, Bedrock is looking at how we can address the key challenges outlined above alongside our patient focused sister agency, Origins. Bedrock and Origins are collaborating to think creatively and compliantly about engagement of patients in the entire publication process. To talk to us about our work in publications and medical communications, and how we improve patient involvement and focus throughout the entire clinical development and lifecycle management process, please contact Louise Adamson louiseadamson@bedrock-health.com

Reference:

  1. DeTora LM, et al. Ann Intern Med. 2022;175(9):1298–304.

This content was provided by Bedrock Healthcare Communications

Documents for download:

Company Details

 Latest Content from  Bedrock Healthcare Communications 

When it’s OK to not be OK: Bedrock breaks down mental health stigma

As part of Bedrock’s Wellbeing Programme, Bedrock paired up with Simpila to talk about mental health challenges and open up about the pressures we all face, both in and out...

Bedrock creates waves

The Bedrock team were awash with ideas at their summer watersports and BBQ event. All were Bravely Bedrock in a host of activities – including wakeboarding, paddle boarding and taming...

Bedrock LEAPs to new heights

What do our future leaders say about LEAP?

Bedrock Group strengthens its senior team

Bedrock strengthen its management team with the recruitment of two senior roles

A postcard from Cannes

This week sees the annual Cannes Lions International Festival of Creativity, bringing together leading creative talent from across the globe to learn, share and inspire each other. Until recently, pharmaceuticals...

A variety of backgrounds, a unified purpose

How did Bedrock become Bedrock? We asked members of the Bedrock team how they found their way into the (somewhat hidden) world of medical communications, and what they love about...

Wanda Lesowiec did it. Could you?

How a background in pharma can mean a bright future in medical communications

Am I wrong to be apprehensive about gene therapy?

Is the introduction of gene therapy going to be smooth sailing? Origin's Strategic Solutions Director, Su Smith, shares her thoughts.

Bedrock Group announces the launch of Origins, a health experience research company

Bedrock Group is proud to announce the launch of Origins, a health experience research company.

Artificial Intelligence: a new character in the storytelling of drug development and discovery?

Written by Edward Jones, Junior Medical Writer. Bedrock is dedicated to creating valuable and powerful stories to engage audiences that drive an improvement in the provision of health. This focus...